JA

Jesal Agarwal

Active Director Nominee Director DIN 06986253
DIN 06986253 First appointment Sep 2014 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Sep 2014
Shareholding value •••• Premium profile

About Jesal Agarwal

Data last updated:

Jesal Agarwal has 12 years in corporate governance. Holds Nominee Director and Additional Director roles. Currently with 4 companies, including Dres Energy Private Limited and Dr. Reddy's Bio-Sciences Limited. Formerly with 1 company, such as Medtronic Engineering And Innovation Center Private Limited. Engaged in General Business. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹660 Cr; the largest is Aurigene Pharmaceutical Services Limited at ₹645 Cr (FY 2025).

DIN 06986253
Primary Designation Nominee Director
First Appointment 29 Sep 2014
Oldest Company Age 26 yrs
Largest company Aurigene Pharmaceutical Services Limited · ₹645 Cr (FY 2025)
Combined revenue ₹660 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20242019₹645 Cr (FY 2025)Active
Dres Energy Private Limited U40104KA2015PTC083148
Nominee Director12 Jun 20242015₹14.09 Cr (FY 2025)Active
Dr. Reddy's Bio-Sciences Limited U72200TG2000PLC034765
Additional Director24 Nov 20252000₹1.20 Cr (FY 2025)Active
Dr. Reddy's Formulations Limited U24299TG2021PLC149527
Ceo04 Jul 20252021₹5.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alternate Director29 Sep 20142011₹667 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dres Energy Private Limited
Dr. Reddy's Bio-Sciences Limited
Dr. Reddy's Formulations Limited
Aurigene Pharmaceutical Services Limited
Premium access

Shareholding and investment profile for Jesal Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jesal Agarwal

Jesal Agarwal has 12 years in corporate governance. Holds Nominee Director and Additional Director roles. Currently with 4 companies, including Dres Energy Private Limited and Dr. Reddy's Bio-Sciences Limited. Formerly with 1 company, such as Medtronic Engineering And Innovation Center Private Limited. Engaged in General Business. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹660 Cr; the largest is Aurigene Pharmaceutical Services Limited at ₹645 Cr (FY 2025).

Jesal Agarwal is associated with 4 companies as Nominee Director and Additional Director, including Aurigene Pharmaceutical Services Limited (₹645 Cr), Dres Energy Private Limited (₹14.09 Cr), Dr. Reddy's Bio-Sciences Limited (₹1.20 Cr).

Jesal Agarwal has expertise in General Business.

Jesal Agarwal has 12 years in corporate governance.

By reported revenue, the largest current company of Jesal Agarwal is Aurigene Pharmaceutical Services Limited, with revenue of ₹645 Cr (FY 2025).

The 4 current companies of Jesal Agarwal that report revenue have a combined latest revenue of ₹660 Cr.

Jesal Agarwal currently holds positions at 4 companies: Aurigene Pharmaceutical Services Limited (₹645 Cr), Dres Energy Private Limited (₹14.09 Cr), Dr. Reddy's Bio-Sciences Limited (₹1.20 Cr), Dr. Reddy's Formulations Limited (₹5.3 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available